Warning: The NCBI web site requires JavaScript to function. more...
Controlling illegal stimulants: a regulated market model.
Haden M.
Harm Reduct J. 2008 Jan 23;5:1.
Related citations
KSR v. Teleflex. Part 2: Impact of U.S Supreme Court Patent Law on Canadian and global systems-based innovation ecologies.
Bouchard RA.
Health Law J. 2007;15:247-94.
Public health, not social warfare: a public health approach to illegal drug policy.
Mosher JF, Yanagisako KL.
J Public Health Policy. 1991 Autumn;12(3):278-323. Review.
[War on Drugs or War against Health? The pitfalls for public health of Puerto Rican drug policy].
Santiago-Negrón S, Albizu-García CE.
P R Health Sci J. 2003 Mar;22(1):49-59. Review. Spanish.
Drugs, communities, and "harm reduction" in Germany: the new relevance of "public health" principles in local responses.
Fischer B.
J Public Health Policy. 1995;16(4):389-411. Review.
Drug prohibition and public health: 25 years of evidence.
Drucker E.
Public Health Rep. 1999 Jan-Feb;114(1):14-29. Review.
Market power in the United States red meatpacking industry.
Koontz SR.
Vet Clin North Am Food Anim Pract. 2003 Jul;19(2):519-44. Review.
Tobacco and cancer: an American Association for Cancer Research policy statement.
Viswanath K, Herbst RS, Land SR, Leischow SJ, Shields PG; Writing Committee for the AACR Task Force on Tobacco and Cancer.
Cancer Res. 2010 May 1;70(9):3419-30. Epub 2010 Apr 13.
Simultaneous strategies to reduce demand for and problematic use of hard drugs.
Broer J, Garretsen HF.
Med Law. 1995;14(3-4):171-9.
Epidemiologic issues pertinent to international regulation of 28 stimulant-hallucinogen drugs.
Anthony JC, Trinkoff AM.
Drug Alcohol Depend. 1986 Jun;17(2-3):193-211.
Civil society-a leader in HIV prevention and tobacco control.
Malinowska-Sempruch K, Bonnell R, Hoover J.
Drug Alcohol Rev. 2006 Nov;25(6):625-32. Review.
Exploring new ethics for public health: developing a fair alcohol policy.
Beauchamp DE.
J Health Polit Policy Law. 1976 Fall;1(3):338-54.
Pharmaceuticals--strategic considerations in health reforms in Pakistan.
Nishtar S.
J Pak Med Assoc. 2006 Dec;56(12 Suppl 4):S100-11.
Philadelphia's community based drug abuse program: broader medical and social concepts.
Schut J.
Int J Clin Pharmacol Biopharm. 1975 Jun;11(4):286-91.
When is alcohol just another drug? Some thoughts on research and policy.
Cook PJ, Reuter P.
Addiction. 2007 Aug;102(8):1183-8. Review.
Implications of social class and race for urban public health policy making: a case study of HIV/AIDS and TB policy in Washington, DC.
Dievler A, Pappas G.
Soc Sci Med. 1999 Apr;48(8):1095-102.
FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST, Pippins RR, Ngai JW.
Food Drug Law J. 2009;64(3):577-98.
The effects of macro-level interventions on addictive behavior.
Pacula RL, Chaloupka FJ.
Subst Use Misuse. 2001 Dec;36(13):1901-22.
European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
Bates C, Fagerström K, Jarvis MJ, Kunze M, McNeill A, Ramström L.
Tob Control. 2003 Dec;12(4):360-7.
The challenges in developing a rational cannabis policy.
Hall W, Lynskey M.
Curr Opin Psychiatry. 2009 May;22(3):258-62. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on